Clinical Trials Directory

Trials / Terminated

TerminatedNCT01103908

Cardiac Output Measurement at the Conclusion of Cardiopulmonary Bypass

Ultrasound Dilution Cardiac Output at the Conclusion of Cardiopulmonary Bypass in Pediatric Patients

Status
Terminated
Phase
Study type
Observational
Enrollment
3 (actual)
Sponsor
Transonic Systems Inc. · Industry
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

Cardiac output, the amount of blood pumped by the heart in one minute, will be measured in pediatric patients undergoing surgery involving cardiopulmonary bypass (CPB). Cardiac output will be measured after cardiopulmonary bypass using a device that employs ultrasound dilution technology. At times, cardiac output will be measured during a procedure called modified ultrafiltration (MUF). The ultrasound dilution cardiac output measurements will be validated or compared with cardiac output measurements made using other FDA approved techniques and devices.

Conditions

Interventions

TypeNameDescription
DEVICEHCE101 Cardiopulmonary Support MonitorMeasurement of cardiac output using ultrasound dilution technology. The ultrasound dilution technology is in the HCE101 Cardiopulmonary Support Monitor.

Timeline

Start date
2010-04-01
Primary completion
2010-12-01
Completion
2011-08-01
First posted
2010-04-15
Last updated
2016-05-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01103908. Inclusion in this directory is not an endorsement.

Cardiac Output Measurement at the Conclusion of Cardiopulmonary Bypass (NCT01103908) · Clinical Trials Directory